0000103623-24-000054.txt : 20240503 0000103623-24-000054.hdr.sgml : 20240503 20240503160455 ACCESSION NUMBER: 0000103623-24-000054 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 24912952 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: ZANTE GREG CENTRAL INDEX KEY: 0001264949 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O SANGAMO BIOSCIENCES, INC STE-A-100 STREET 2: POINT RICHMOND TECH, 501 CANAL BLVD, CITY: RICHMOND STATE: CA ZIP: 94804 144 1 primary_doc.xml 144 0001264949 XXXXXXXX LIVE 0001607678 Viking Therapeutics, Inc. 001-37355 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660 ZANTE GREG Officer Common Oppenheimer & Co Inc

85 Broad Street New York NY 10004

66756 4983958.00 110268210 05/03/2024 NASDAQ common 05/19/2023 ESPP Issuer N 1169 05/03/2024 N/A common 11/20/2023 ESPP Issuer N 9942 05/03/2024 N/A common 04/03/2023 RSU Issuer N 750 05/03/2024 N/A common 04/03/2023 RSU Issuer N 750 05/03/2024 N/A common 01/03/2024 RSU Issuer N 10101 05/03/2024 N/A common 01/03/2024 RSU Issuer N 2111 05/03/2024 N/A common 01/04/2024 RSU Issuer N 7684 05/03/2024 N/A Y Sales pursuant to a 10b5-1 trading plan on file dated 2/2/2024 - POA on file 05/03/2024 02/02/2024 Greg Zante